ID   SPYMEG
AC   CVCL_VG38
DR   Wikidata; Q54955594
RX   Patent=US8173425;
RX   PubMed=29669959;
WW   http://www.mbl.co.jp/e/r_and_d/spymeg.html
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10761.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0425 ! MEG-01
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
RX   Patent=US8173425;
RA   Yamamoto N., Kaneda M.;
RT   "Fusion partner cells.";
RL   Patent number US8173425, 08-May-2012.
//
RX   PubMed=29669959; DOI=10.1292/jvms.18-0146;
RA   Soni P., Yasuhara A., Takenaga T., Iwatsuki-Horimoto K., Uraki R.,
RA   Ito M., Sasaki T., Ikuta K., Yamayoshi S., Kawaoka Y.;
RT   "Evaluation of the fusion partner cell line SPYMEG for obtaining human
RT   monoclonal antibodies against influenza B virus.";
RL   J. Vet. Med. Sci. 80:1020-1024(2018).
//